Improvement of B Cell Responses by an HIV-1 Amphiphilic Polymer Nanovaccine
The human immunodeficiency virus (HIV) has infected over 84 million people since its discovery and is a huge threat to human health. While an HIV vaccine is urgently needed to curb this devastating pandemic, it has been notoriously difficult to develop, partly due to the extraordinary high level of...
Main Authors: | Chang, Y. (Author), Gao, F. (Author), Guo, L. (Author), Liu, X. (Author), Liu, Y. (Author), Lu, D. (Author), Shan, Y. (Author), Wan, M. (Author), Wang, H. (Author), Xin, X. (Author), Zhang, Q. (Author), Zhang, Y. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2023
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Properties of HIV-1 env and human seminal fluid that determine virus inhibition by antibodies and microbicides
by: Johnson, Jacklyn
Published: (2019) -
Understanding the Process of Envelope Glycoprotein Incorporation into Virions in Simian and Feline Immunodeficiency Viruses
by: José L. Affranchino, et al.
Published: (2014-01-01) -
Prediction of exposed domains of envelope glycoprotein in Indian HIV-1 isolates and experimental confirmation of their immunogenicity in humans
by: Mohabatkar H., et al.
Published: (2004-01-01) -
Analysis of the relationship between human cytomegalovirus DNA and gB-1 genotype in the saliva of HIV/AIDS patients with xerostomia and salivary flow rate
by: Irna Sufiawati, et al.
Published: (2019-12-01) -
Etude de la réponse humorale neutralisante contre le Virus de l’Hépatite C
by: Ndongo Thiam, Ndiémé
Published: (2010)